306 related articles for article (PubMed ID: 26837851)
21. Effect of cognitive-behavioral therapy on neural correlates of fear conditioning in panic disorder.
Kircher T; Arolt V; Jansen A; Pyka M; Reinhardt I; Kellermann T; Konrad C; Lueken U; Gloster AT; Gerlach AL; Ströhle A; Wittmann A; Pfleiderer B; Wittchen HU; Straube B
Biol Psychiatry; 2013 Jan; 73(1):93-101. PubMed ID: 22921454
[TBL] [Abstract][Full Text] [Related]
22. Olanzapine augmentation in treatment-resistant panic disorder: a 12-week, fixed-dose, open-label trial.
Sepede G; De Berardis D; Gambi F; Campanella D; La Rovere R; D'Amico M; Cicconetti A; Penna L; Peca S; Carano A; Mancini E; Salerno RM; Ferro FM
J Clin Psychopharmacol; 2006 Feb; 26(1):45-9. PubMed ID: 16415705
[TBL] [Abstract][Full Text] [Related]
23. Effect of dissociative experiences on drug treatment of panic disorder.
Gulsun M; Doruk A; Uzun O; Turkbay T; Ozsahin A
Clin Drug Investig; 2007; 27(8):583-90. PubMed ID: 17638399
[TBL] [Abstract][Full Text] [Related]
24. Orexin in the anxiety spectrum: association of a HCRTR1 polymorphism with panic disorder/agoraphobia, CBT treatment response and fear-related intermediate phenotypes.
Gottschalk MG; Richter J; Ziegler C; Schiele MA; Mann J; Geiger MJ; Schartner C; Homola GA; Alpers GW; Büchel C; Fehm L; Fydrich T; Gerlach AL; Gloster AT; Helbig-Lang S; Kalisch R; Kircher T; Lang T; Lonsdorf TB; Pané-Farré CA; Ströhle A; Weber H; Zwanzger P; Arolt V; Romanos M; Wittchen HU; Hamm A; Pauli P; Reif A; Deckert J; Neufang S; Höfler M; Domschke K
Transl Psychiatry; 2019 Feb; 9(1):75. PubMed ID: 30718541
[TBL] [Abstract][Full Text] [Related]
25. Neural correlates of NOS1 ex1f-VNTR allelic variation in panic disorder and agoraphobia during fear conditioning and extinction in fMRI.
Ridderbusch IC; Yang Y; Weber H; Reif A; Herterich S; Ströhle A; Pfleiderer B; Arolt V; Wittchen HU; Lueken U; Kircher T; Straube B
Neuroimage Clin; 2020; 27():102268. PubMed ID: 32361414
[TBL] [Abstract][Full Text] [Related]
26. Association of rs7688285 allelic variation coding for GLRB with fear reactivity and exposure-based therapy in patients with panic disorder and agoraphobia.
Ridderbusch IC; Richter J; Yang Y; Hoefler M; Weber H; Reif A; Hamm A; Pané-Farré CA; Gerlach AL; Stroehle A; Pfleiderer B; Arolt V; Wittchen HU; Gloster A; Lang T; Helbig-Lang S; Fehm L; Pauli P; Kircher T; Lueken U; Straube B
Eur Neuropsychopharmacol; 2019 Oct; 29(10):1138-1151. PubMed ID: 31444036
[TBL] [Abstract][Full Text] [Related]
27. Treatment of panic disorder with agoraphobia in an anxiety disorders clinic: factors influencing psychiatrists' treatment choices.
Starcevic V; Linden M; Uhlenhuth EH; Kolar D; Latas M
Psychiatry Res; 2004 Jan; 125(1):41-52. PubMed ID: 14967551
[TBL] [Abstract][Full Text] [Related]
28. Early improvement predicts endpoint remission status in sertraline and placebo treatments of panic disorder.
Pollack MH; Rapaport MH; Fayyad R; Otto MW; Nierenberg AA; Clary CM
J Psychiatr Res; 2002; 36(4):229-36. PubMed ID: 12191627
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and treatment of agoraphobia with panic disorder.
Perugi G; Frare F; Toni C
CNS Drugs; 2007; 21(9):741-64. PubMed ID: 17696574
[TBL] [Abstract][Full Text] [Related]
30. Cost-effectiveness of CBT, SSRI, and CBT+SSRI in the treatment for panic disorder.
van Apeldoorn FJ; Stant AD; van Hout WJ; Mersch PP; den Boer JA
Acta Psychiatr Scand; 2014 Apr; 129(4):286-95. PubMed ID: 23834587
[TBL] [Abstract][Full Text] [Related]
31. Milnacipran in panic disorder with agoraphobia and major depressive disorder: a case report.
Chen MH; Liou YJ
Clin Neuropharmacol; 2011; 34(5):201-2. PubMed ID: 21926486
[TBL] [Abstract][Full Text] [Related]
32. Personality traits in early phases of panic disorder: implications on the presence of agoraphobia, clinical severity and short-term outcome.
Carrera M; Herrán A; Ramírez ML; Ayestarán A; Sierra-Biddle D; Hoyuela F; Rodríguez-Cabo B; Vázquez-Barquero JL
Acta Psychiatr Scand; 2006 Dec; 114(6):417-25. PubMed ID: 17087790
[TBL] [Abstract][Full Text] [Related]
33. Running for extinction? Aerobic exercise as an augmentation of exposure therapy in panic disorder with agoraphobia.
Bischoff S; Wieder G; Einsle F; Petzold MB; Janßen C; Mumm JLM; Wittchen HU; Fydrich T; Plag J; Ströhle A
J Psychiatr Res; 2018 Jun; 101():34-41. PubMed ID: 29539585
[TBL] [Abstract][Full Text] [Related]
34. The relationship between agoraphobia symptoms and panic disorder in a non-clinical sample of adolescents.
Hayward C; Killen JD; Taylor CB
Psychol Med; 2003 May; 33(4):733-8. PubMed ID: 12785475
[TBL] [Abstract][Full Text] [Related]
35. Cognitive-behavior therapy for discontinuation of SSRI treatment of panic disorder: a case series.
Whittal ML; Otto MW; Hong JJ
Behav Res Ther; 2001 Aug; 39(8):939-45. PubMed ID: 11480834
[TBL] [Abstract][Full Text] [Related]
36. Anticipating agoraphobic situations: the neural correlates of panic disorder with agoraphobia.
Wittmann A; Schlagenhauf F; Guhn A; Lueken U; Gaehlsdorf C; Stoy M; Bermpohl F; Fydrich T; Pfleiderer B; Bruhn H; Gerlach AL; Kircher T; Straube B; Wittchen HU; Arolt V; Heinz A; Ströhle A
Psychol Med; 2014 Aug; 44(11):2385-96. PubMed ID: 24398049
[TBL] [Abstract][Full Text] [Related]
37. A randomized, controlled trial of the effectiveness of cognitive-behavioral therapy and sertraline versus a waitlist control group for anxiety disorders in older adults.
Schuurmans J; Comijs H; Emmelkamp PM; Gundy CM; Weijnen I; van den Hout M; van Dyck R
Am J Geriatr Psychiatry; 2006 Mar; 14(3):255-63. PubMed ID: 16505130
[TBL] [Abstract][Full Text] [Related]
38. An open study of the effectiveness of Internet treatment for panic disorder delivered in a psychiatric setting.
Bergström J; Andersson G; Karlsson A; Andréewitch S; Rück C; Carlbring P; Lindefors N
Nord J Psychiatry; 2009; 63(1):44-50. PubMed ID: 18985514
[TBL] [Abstract][Full Text] [Related]
39. [Gender differences in psychopathologic features of agoraphobia with panic disorder].
Latas M; Mitrović M; Starcević V
Vojnosanit Pregl; 2006 Jun; 63(6):569-74. PubMed ID: 16796023
[TBL] [Abstract][Full Text] [Related]
40. Separating depressive comorbidity from panic disorder: A combined functional magnetic resonance imaging and machine learning approach.
Lueken U; Straube B; Yang Y; Hahn T; Beesdo-Baum K; Wittchen HU; Konrad C; Ströhle A; Wittmann A; Gerlach AL; Pfleiderer B; Arolt V; Kircher T
J Affect Disord; 2015 Sep; 184():182-92. PubMed ID: 26093832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
